Entity Common Stock, Shares Outstanding of KalVista Pharmaceuticals, Inc. from 30 Apr 2015 to 29 Aug 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
KalVista Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Apr 2015 to 29 Aug 2025.
  • KalVista Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 29 Aug 2025 was 50,523,274, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,523,274 +7,307,802 +17% 29 Aug 2025 10-Q 11 Sep 2025 2026 Q1
Q2 2025 49,953,739 +7,218,092 +17% 25 Jun 2025 10-K 10 Jul 2025 2025 FY
Q1 2025 49,715,636 +7,527,340 +18% 07 Mar 2025 10-Q 12 Mar 2025 2025 Q3
Q4 2024 49,417,986 +14,859,277 +43% 04 Dec 2024 10-Q 05 Dec 2024 2025 Q2
Q3 2024 43,215,472 +8,812,014 +26% 26 Aug 2024 10-Q 05 Sep 2024 2025 Q1
Q2 2024 42,735,647 +8,502,004 +25% 25 Jun 2024 10-K 11 Jul 2024 2024 FY
Q1 2024 42,188,296 +8,018,858 +23% 29 Feb 2024 10-Q 11 Mar 2024 2024 Q3
Q4 2023 34,558,709 +9,940,559 +40% 30 Nov 2023 10-Q 07 Dec 2023 2024 Q2
Q3 2023 34,403,458 +9,801,435 +40% 31 Aug 2023 10-Q 07 Sep 2023 2024 Q1
Q2 2023 34,233,643 +9,662,771 +39% 28 Jun 2023 10-K 10 Jul 2023 2023 FY
Q1 2023 34,169,438 +9,626,182 +39% 01 Mar 2023 10-Q 09 Mar 2023 2023 Q3
Q4 2022 24,618,150 +148,349 +0.61% 01 Dec 2022 10-Q 08 Dec 2022 2023 Q2
Q3 2022 24,602,023 +164,157 +0.67% 01 Sep 2022 10-Q 08 Sep 2022 2023 Q1
Q2 2022 24,570,872 +134,380 +0.55% 02 Jul 2022 10-K 07 Jul 2022 2022 FY
Q1 2022 24,543,256 +235,065 +0.97% 08 Mar 2022 10-Q 10 Mar 2022 2022 Q3
Q4 2021 24,469,801 +6,527,635 +36% 07 Dec 2021 10-Q 09 Dec 2021 2022 Q2
Q3 2021 24,437,866 +6,530,307 +36% 07 Sep 2021 10-Q 09 Sep 2021 2022 Q1
Q2 2021 24,436,492 +6,589,268 +37% 02 Jul 2021 10-K 13 Jul 2021 2021 FY
Q1 2021 24,308,191 +6,462,592 +36% 04 Mar 2021 10-Q 11 Mar 2021 2021 Q3
Q4 2020 17,942,166 +108,040 +0.61% 03 Dec 2020 10-Q 10 Dec 2020 2021 Q2
Q3 2020 17,907,559 +92,066 +0.52% 04 Sep 2020 10-Q 14 Sep 2020 2021 Q1
Q2 2020 17,847,224 +458,926 +2.6% 24 Jun 2020 10-K 01 Jul 2020 2020 FY
Q1 2020 17,845,599 +598,251 +3.5% 02 Mar 2020 10-Q 10 Mar 2020 2020 Q3
Q4 2019 17,834,126 +608,459 +3.5% 30 Nov 2019 10-Q 03 Dec 2019 2020 Q2
Q3 2019 17,815,493 +635,806 +3.7% 30 Aug 2019 10-Q 09 Sep 2019 2020 Q1
Q2 2019 17,388,298 +6,588,403 +61% 01 Jul 2019 10-K 16 Jul 2019 2019 FY
Q1 2019 17,247,348 +6,451,453 +60% 10 Mar 2019 10-Q 14 Mar 2019 2019 Q3
Q4 2018 17,225,667 +6,441,163 +60% 10 Dec 2018 10-Q 14 Dec 2018 2019 Q2
Q3 2018 17,179,687 +7,466,645 +77% 10 Sep 2018 10-Q 14 Sep 2018 2019 Q1
Q2 2018 10,799,895 +1,086,853 +11% 16 Jul 2018 10-K 30 Jul 2018 2018 FY
Q1 2018 10,795,895 +1,082,853 +11% 01 Mar 2018 10-Q 16 Mar 2018 2018 Q3
Q4 2017 10,784,504 30 Nov 2017 10-Q 14 Dec 2017 2018 Q2
Q3 2017 9,713,042 -16,631,062 -63% 31 Aug 2017 10-Q 14 Sep 2017 2018 Q1
Q2 2017 9,713,042 -16,622,733 -63% 01 Jul 2017 10-K 27 Jul 2017 2017 FY
Q1 2017 9,713,042 -16,619,452 -63% 28 Feb 2017 10-Q 16 Mar 2017 2016 Q3
Q3 2016 26,344,104 +21,610 +0.08% 31 Oct 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 26,335,775 +13,281 +0.05% 29 Jul 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 26,332,494 +118,387 +0.45% 15 Mar 2016 10-K 30 Mar 2016 2015 FY
Q3 2015 26,322,494 31 Oct 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 26,322,494 31 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 26,214,107 30 Apr 2015 10-Q 21 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.